Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 3 Warts 1 Uveal Melanoma 1 Tuberous Sclerosis 1 Seizures 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell 1 Lennox Gastaut Syndrome 1 Hyperthermia 1 Hemorrhage 1 Hematologic Neoplasms 1 Glioblastoma 1 Epilepsies, Myoclonic 1 Brain Neoplasms 1

Interventions

Temozolomide 100 Radiotherapy 49 Magnetic Resonance Spectroscopy 38 Radiation 28 Specimen Handling 25 pembrolizumab 22 Bevacizumab 22 Lomustine 16 Nivolumab 14 Surgical Procedures, Operative 10 atezolizumab 8 Cyclophosphamide 8 Biopsy 8 abemaciclib 7 Ipilimumab 7 fludarabine 6 Radiotherapy, Intensity-Modulated 6 Carboplatin 6 Aminolevulinic Acid 6 olaparib 5 Metformin 5 Drug Therapy 5 Diet, Ketogenic 5 Dianhydrogalactitol 5 poly ICLC 4 cemiplimab 4 Radiosurgery 4 Photons 4 Leukapheresis 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Solutions × 1 year × Clear all

NCT03233152 2025-11-21

GlitIpNi

Universitair Ziekenhuis Brussel

Phase 1/2 Active not recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡